Burzynski Research Institute, Inc. (BZYR)
OTCMKTS · Delayed Price · Currency is USD
0.0250
0.00 (0.00%)
Mar 4, 2026, 4:00 PM EST
BZYR Market Cap
BZYR has a market cap or net worth of $3.29 million as of March 5, 2026. Its market cap has decreased by -56.82% in one year.
Market Cap
3.29M
Enterprise Value
3.28M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since April 28, 1997, BZYR's market cap has decreased from 16.41M to 3.29M, a decrease of -79.98%. That is a compound annual growth rate of -5.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 3.29M | 30.89% |
| Dec 29, 2025 | 2.51M | -38.39% |
| Dec 31, 2024 | 4.07M | -29.55% |
| Dec 29, 2023 | 5.78M | 70.28% |
| Dec 23, 2022 | 3.40M | 115.33% |
| Dec 31, 2021 | 1.58M | -33.33% |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enzon Pharmaceuticals | 4.50M |
| GPL Holdings | 4.17M |
| Mosaic ImmunoEngineering | 4.01M |
| AXIM Biotechnologies | 3.99M |
| Galera Therapeutics | 3.68M |
| Clearside Biomedical | 3.58M |
| Vaccinex | 3.35M |
| ProtoKinetix | 2.73M |